Results 121 to 130 of about 694,618 (154)

Implementing Laparoscopic Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): First Case at Our Institution

Peritoneal carcinomatosis represents a challenge to manage. These metastases have a reduced response to systemic chemotherapy due to poor peritoneal vascularization [1].
Sand, Emma, Wong-Gillam, Tina
core   +1 more source

Feasibility of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a Rabbit Model of Peritoneal Metastases: PIPALIM Project. [PDF]

Ann Surg Oncol
Bardet SM, Perrin ML, David V, Yardin C, Chaunavel A, Durand K, Maillan G, Rouchaud A, Durand Fontanier S, Taibi A.   +9 more
europepmc   +1 more source

Advances in Bidirectional Therapy for Peritoneal Metastases: A Systematic Review of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Combined with Systemic Chemotherapy. [PDF]

Cancers (Basel)
Robella M, Vitturini M, Di Giorgio A, Aulicino M, Hubner M, Koumantakis E, Borghi F, Catania P, Cinquegrana A, Berchialla P.   +9 more
europepmc   +1 more source

Current Medical Care Situation of Patients in Germany Undergoing Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). [PDF]

Cancers (Basel), 2022
Horvath P, Yurttas C, Baur I, Steidle C, Reymond MA, Girotti PNC, Königsrainer A, Königsrainer I.   +7 more
europepmc   +1 more source

Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety. [PDF]

Gastroenterol Rep (Oxf)
Chen R, Yang Z, Li R, Yang Y, Zheng J, Wang J, Li Y.   +6 more
europepmc   +1 more source

Comparison of Three Nebulizer Nozzles Used During Pressurized Intraperitoneal Aerosol Chemotherapy Procedures in a Rabbit Model with Peritoneal Surface Malignancies: NOMOS Project. [PDF]

Ann Surg Oncol
Taibi A, Perrin ML, Yardin C, Usseglio J, Durand Fontanier S, Bardet SM.   +5 more
europepmc   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis in Colorectal Cancer Patients: A Systematic Review of the Evidence. [PDF]

Cancers (Basel)
Sleiman MJ, Jelip A, Buchs N, Toso C, Liot E, Koessler T, Meyer J, Meurette G, Ris F.   +8 more
europepmc   +1 more source

Predictive Factors for the Discontinuation of Pressurized Intraperitoneal Aerosol Chemotherapy: Enhancing Patient Selection to Improve Oncological Outcomes-A Single-Center Experience. [PDF]

Cancers (Basel)
Aulicino M, Santullo F, Orsini C, D'Agostino L, Hübner M, Texeira-Farinha H, Robella M, Sgarbura O, Bianco A, Ben-Yaacov A, Ferracci F, D'Annibale G, Pacelli F, Di Giorgio A.   +13 more
europepmc   +1 more source

A novel nebulized drug delivery system based on an innovative high-pressure peristaltic pump availably applied to pressurized intraperitoneal aerosol chemotherapy. [PDF]

J Gastrointest Oncol
Li R, Fan Q, Lin X, Chen R, Luo B, Yang Z, Li Y.   +6 more
europepmc   +1 more source

Performance of different nebulizers in clinical use for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). [PDF]

PLoS One
Göhler D, Oelschlägel K, Ouaissi M, Giger-Pabst U.   +3 more
europepmc   +1 more source